Bioxytran, Inc (BIXT) stock

BIXTOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30

$0.02−0.00 (-3.95%)

Close on Oct 19, 2026Market cap $2.56MP/E –Yield –

Bioxytran price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Bioxytran's price to book ratio was 100.9× on Oct 31, 2018.

Period	Period end	Value	Change (pts)
2018	Oct 31, 2018	100.9×	−309.1
2013	Apr 30, 2013	410.0×	–

See a number that looks wrong?